Dharuhera Pharmaceuticals Pvt Ltd

Dharuhera Pharmaceuticals Pvt Ltd - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
CIN U24239DL1981PTC011495 Incorporated 26 March 1981 ROC Delhi HQ New Delhi, Delhi, India
Active Private Limited Company pharma MSME · Small
Data last updated
Revenue · FY 2025
₹3.83 Cr
▼ 79% YoY
Net loss · FY 2025
₹5.55 Cr
Net margin -144.9%
EBITDA · FY 2025
-₹3.52 Cr
EBITDA margin -91.9%
Authorised capital
₹5.81 Cr
Registered with MCA
Paid-up capital
₹2.4 Cr
Issued & subscribed
Open charges
₹10 Lakh
Secured borrowings
Company age
45 yrs
Est. 1981
Employees · EPFO
34
Provident fund records

About Dharuhera Pharmaceuticals Pvt Ltd

Data last updated:

Dharuhera Pharmaceuticals Pvt Ltd is a private limited company based in New Delhi, Delhi, India, a subsidiary of Rakshit Organisational Operations And Transformations Private Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 26 March 1981 and has been in existence for over 45 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24239DL1981PTC011495. Its GSTIN is 07AAACD6802C1Z7 (Delhi). The company holds 6 GST registrations, of which 2 are active.

The company has an authorised share capital of ₹5.81 Cr and a paid-up capital of ₹2.4 Cr. It is led by directors including Main Pal Singh and Jasvir Singh.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 10 Jorbagh Market, New Delhi, Delhi, India – 110003.

As per the financials filed for FY 2025, the company reported a revenue of ₹3.83 Cr, a decline of 79% compared to the previous year. For the same year it recorded a net loss of ₹5.55 Cr (net margin -144.9%) and EBITDA of -₹3.52 Cr (EBITDA margin -91.9%). Revenue has declined at a compounded annual rate (CAGR) of 27% over three years and 8% over five years.

The company has about 34 employees on its provident fund (EPFO) records.

As per MCA filings, the company has open charges of ₹10 Lakh on record. Court records list 5 cases involving the company, including 3 filed by the company and 2 filed against it.

Dharuhera Pharmaceuticals Pvt Ltd is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-08-0044968). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website dharuherapharma.com.

Company details

CIN U24239DL1981PTC011495
Registration Number 011495
Incorporation Date 26 March 1981
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Parent Company Rakshit Organisational Operations And Transformations Private Limited
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-DL-08-0044968

Recognitions & Rankings of Dharuhera Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Small (2024-25)
Udyam number
UDYAM-DL-08-0044968

Contact details

Dharuhera Pharmaceuticals Pvt Ltd's registered office is in New Delhi, Delhi. Its website is dharuherapharma.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    10 Jorbagh Market, New Delhi, Delhi, India – 110003
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Dharuhera Pharmaceuticals Pvt Ltd, buy the company report.

Comprehensive company report
Dharuhera Pharmaceuticals Pvt Ltd - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Dharuhera Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Dharuhera Pharmaceuticals Pvt Ltd, buy the company report.

Financials of Dharuhera Pharmaceuticals Pvt Ltd

FY 2024 filings available

Dharuhera Pharmaceuticals Pvt Ltd reported revenue of ₹3.83 Cr (down 79% YoY) for FY 2025.

Revenue · FY 2025
₹3.83 Cr ▼ 79%
Net loss · FY 2025
₹5.55 Cr margin -144.9%
EBITDA · FY 2025
-₹3.52 Cr margin -91.9%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 79%
3 years · compounded
▼ 27%
5 years · compounded
▼ 8%
EBITDA CAGR growth
1 year
▼ 209%
3 years · compounded
▼ 54%
5 years · compounded
▼ 89%

Revenue has declined at a compounded annual rate (CAGR) of 8% over five years, including a 79% fall in the latest year. EBITDA fell 209% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹3.52 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹5.55 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin-91.9%
Net Profit Margin-144.9%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Dharuhera Pharmaceuticals Pvt Ltd, buy the company report.

Board of directors of Dharuhera Pharmaceuticals Pvt Ltd

Dharuhera Pharmaceuticals has 3 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Main Pal SinghDirector19 Jan 20224 Years 9 MonthsCurrent
Jasvir SinghDirector24 Jan 20251 Years 8 MonthsCurrent
Rajpal Singh KochharDirector12 Sep 20224 Years 1 MonthsCurrent

Peer comparison

Dharuhera Pharmaceuticals Pvt Ltd is compared with the 5 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Samai Healthcare Private Limited₹3.84 Cr (FY 2024)15.0%Mumbai, Maharashtra, India
Dial Pharmaceuticals Private Limited₹3.84 Cr (FY 2025)-3.0%Ahmedabad, Gujarat, India
Alive Lifescience Private Limited₹3.83 Cr (FY 2025)3.0%Ahmedabad, Gujarat, India
Dharuhera Pharmaceuticals Pvt Ltdthis company₹3.83 Cr (FY 2025)-₹5.55 Cr-144.9%-79.0%34New Delhi, Delhi, India
Alentica Pharmaceuticals Private Limited₹3.83 Cr (FY 2025)16.0%Hyderabad, Telangana, India
Wellbert Pharmaceuticals (Bombay) Pvt Ltd₹3.81 Cr (FY 2017)45.0%Mumbai, Maharashtra, India

To see the full peer comparison of Dharuhera Pharmaceuticals Pvt Ltd, buy the company report.

Auditor

Dharuhera Pharmaceuticals Pvt Ltd is audited by Suresh Sethi & Co. for the financial year 2023.

Auditor firmFinancial yearFirm registration number
Suresh Sethi & Co.FY 2023010700N

Shareholding

The shareholding of Dharuhera Pharmaceuticals Pvt Ltd is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Dharuhera Pharmaceuticals Pvt Ltd, buy the company report.

Charges & borrowings

Open charges
₹10 Lakh
Satisfied charges
None
Breakdown by lending institutions
State Bank of India₹0.10 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
17 Feb 198690333967State Bank of India₹10 LakhOpen

Total charge records: 1 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Dharuhera Pharmaceuticals Pvt Ltd; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Dharuhera Pharmaceuticals Pvt Ltd has a workforce of 34 employees on its EPFO records as of Apr 05, 2024, across 1 active EPFO establishment.

Employee count
34
Active EPFO establishments
1
Employee growth
-8.11%

GST

Dharuhera Pharmaceuticals has 6 GST registrations: 2 active and 4 cancelled or inactive.

Total GSTINs
6
Active
2
Cancelled / inactive
4
GSTINStateStatusRegistered on
07AAACD6802C1Z7DelhiActive01 Jul 2017
06AAACD6802C1Z9HaryanaActive01 Jul 2017

To see the full GST registrations and return filing status of Dharuhera Pharmaceuticals Pvt Ltd, buy the company report.

Recent activity

Dharuhera Pharmaceuticals Pvt Ltd has 10 board changes on record since 2021: 3 appointments and 7 cessations. The latest: Jasvir Singh ceased to be Additional Director on 16 Dec 2025.

Ceased
Jasvir Singh ceased to be Additional Director.
Appointed
Jasvir Singh was appointed as Director.
AGM
Dharuhera Pharmaceuticals Pvt Ltd last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Dharuhera Pharmaceuticals Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
Ceased
Main Pal Singh ceased to be Additional Director.
Ceased
Rajpal Singh Kochhar ceased to be Additional Director.
Appointed
Rajpal Singh Kochhar was appointed as Director.
Ceased
Upendra Nath Senapati ceased to be Additional Director.
Ceased
Vidarsh Chopra ceased to be Director.
Appointed
Main Pal Singh was appointed as Director.
Ceased
Salapaka Venkata Subha Rao ceased to be Director.
Ceased
Sanjiv Kumar Dudeja ceased to be Director.

2 earlier events are in the company report.

Frequently asked questions

Dharuhera Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 26 March 1981 (45+ years old) and is registered under CIN U24239DL1981PTC011495.

Dharuhera Pharmaceuticals has 3 current directors:

The latest financial statements of Dharuhera Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.

The GSTIN of Dharuhera Pharmaceuticals is 07AAACD6802C1Z7, registered in Delhi. The company has 6 GST registrations in all, of which 2 are active and 4 are cancelled or inactive. Other active GSTINs include 06AAACD6802C1Z9 (Haryana).

The CIN (Corporate Identification Number) of Dharuhera Pharmaceuticals is U24239DL1981PTC011495. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Dharuhera Pharmaceuticals has 5 court cases on record: 3 filed by the company and 2 filed against it. Most are in the district courts.

Dharuhera Pharmaceuticals was incorporated on 26 March 1981, making it 45+ years old. It is registered with the Registrar of Companies, Delhi.

The peers of Dharuhera Pharmaceuticals by revenue are Samai Healthcare Private Limited, Dial Pharmaceuticals Private Limited, Alive Lifescience Private Limited, Alentica Pharmaceuticals Private Limited, Wellbert Pharmaceuticals (Bombay) Pvt Ltd, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Jasvir Singh ceased to be Additional Director on 16 Dec 2025. Jasvir Singh was appointed as Director on 24 Jan 2025. Main Pal Singh ceased to be Additional Director on 30 Sep 2022. Dharuhera Pharmaceuticals has 10 board changes on record in total.

Yes, Dharuhera Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-DL-08-0044968).

Dharuhera Pharmaceuticals can be reached through the website dharuherapharma.com. Its registered office is in New Delhi, Delhi, India.